Neurath A Robert, Strick Nathan, Li Yun-Yao
Biochemical Virology Laboratory, The Lindsley F, Kimball Research Institute of the New York Blood Center, New York, NY 10021, USA.
BMC Infect Dis. 2006 Oct 16;6:150. doi: 10.1186/1471-2334-6-150.
Evaluation of microbicides for prevention of HIV-1 infection in macaque models for vaginal infection has indicated that the concentrations of active compounds needed for protection by far exceed levels sufficient for complete inhibition of infection in vitro. These experiments were done in the absence of seminal plasma (SP), a vehicle for sexual transmission of the virus. To gain insight into the possible effect of SP on the performance of selected microbicides, their anti-HIV-1 activity in the presence, and absence of SP, was determined.
The inhibitory activity of compounds against the X4 virus, HIV-1 IIIB, and the R5 virus, HIV-1 BaL was determined using TZM-bl indicator cells and quantitated by measuring beta-galactosidase induced by infection. The virucidal properties of cellulose acetate 1,2-benzene-dicarboxylate (CAP), the only microbicide provided in water insoluble, micronized form, in the presence of SP was measured.
The HIV-1 inhibitory activity of the polymeric microbicides, poly(naphthalene sulfonate), cellulose sulfate, carrageenan, CAP (in soluble form) and polystyrene sulfonate, respectively, was considerably (range approximately 4 to approximately 73-fold) diminished in the presence of SP (33.3%). Formulations of micronized CAP, providing an acidic buffering system even in the presence of an SP volume excess, effectively inactivated HIV-1 infectivity.
The data presented here suggest that the in vivo efficacy of polymeric microbicides, acting as HIV-1 entry inhibitors, might become at least partly compromised by the inevitable presence of SP. These possible disadvantages could be overcome by combining the respective polymers with acidic pH buffering systems (built-in for formulations of micronized CAP) or with other anti-HIV-1 compounds, the activity of which is not affected by SP, e.g. reverse transcriptase and zinc finger inhibitors.
在猕猴阴道感染模型中评估杀微生物剂预防HIV-1感染的研究表明,提供保护所需的活性化合物浓度远远超过体外完全抑制感染所需的水平。这些实验是在没有精液(SP)的情况下进行的,而精液是病毒性传播的载体。为了深入了解SP对所选杀微生物剂性能的可能影响,测定了它们在有和没有SP存在时的抗HIV-1活性。
使用TZM-bl指示细胞测定化合物对X4病毒HIV-1 IIIB和R5病毒HIV-1 BaL的抑制活性,并通过测量感染诱导的β-半乳糖苷酶进行定量。测定了醋酸纤维素1,2-苯二甲酸酯(CAP)(唯一以水不溶性微粉化形式提供的杀微生物剂)在SP存在下的杀病毒特性。
在存在SP(33.3%)的情况下,聚合杀微生物剂聚(萘磺酸盐)、硫酸纤维素、角叉菜胶、CAP(可溶形式)和聚苯乙烯磺酸盐的HIV-1抑制活性分别显著降低(范围约为4至约73倍)。即使在SP体积过量的情况下,提供酸性缓冲系统的微粉化CAP制剂也能有效灭活HIV-1传染性。
此处提供的数据表明,作为HIV-1进入抑制剂的聚合杀微生物剂的体内疗效可能至少部分受到SP不可避免存在的影响。通过将各自的聚合物与酸性pH缓冲系统(微粉化CAP制剂中内置)或与其他抗HIV-1化合物(其活性不受SP影响,例如逆转录酶和锌指抑制剂)结合,可以克服这些可能的缺点。